Thiol/disulfide homeostasis in postmenopausal osteoporosis

Journal of Endocrinological Investigation

Volumn 40, Issue 4, 2017, Pages 431-435

  Korkmaz, V ^a   Kurdoglu, Z ^a   Alisik, M ^b   Turgut, E ^a   Sezgin O O ^a   Korkmaz, H ^c   Ergun, Y ^a   Erel, O ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Disulfide; Postmenopausal osteoporosis; Thiol

Indexed keywords

DISULFIDE; THIOL; THIOL DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; MENOPAUSE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS;

CASE-CONTROL STUDIES; DISULFIDES; FEMALE; HOMEOSTASIS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PROGNOSIS; SULFHYDRYL COMPOUNDS;

EID: 85016088997     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-016-0585-7     Document Type: Article

References (24)

1. Mendoza N, Sanchez-Borrego R, Villero J et al (2013) 2013 Up-date of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis. Maturitas 76:99–107
2. Ishtiaq S, Fogelman I, Hampson G (2015) Treatment of post-menopausal osteoporosis: beyond bisphosphonates. J Endocrinol Invest 38(1):13–29. doi:10.1007/s40618-014-0152-z
3. Vescini F, Attanasio R, Balestrieri A, Bandeira F, Bonadonna S, Camozzi V, Cassibba S, Cesareo R, Chiodini I, Francucci CM, Gianotti L, Grimaldi F, Guglielmi R, Madeo B, Marcocci C, Palermo A, Scillitani A, Vignali E, Rochira V, Zini M (2016) Italian association of clinical endocrinologists (AME) position statement: drug therapy of steoporosis. J Endocrinol Invest 39(7):807–834
4. Cairoli E, Zhukouskaya VV, Eller-Vainicher C, Chiodini I (2015) Perspectives on osteoporosis therapies. J Endocrinol Invest 38(3):303–311
5. Altindag O, Erel O, Soran N, Celik H, Selek S (2008) Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 28(4):317–321
6. Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266–300
7. Turell L, Radi R, Alvarez B (2013) The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 65:244–253
8. Eren Y, Dirik E, Nes¸eliog ˘lu S et al (2015) Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study. Acta Neurol Belg 115:643–649
9. Jones DP, Liang Y (2009) Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med 47:1329–1338
10. Korkmaz V, Kurdoglu Z, Alisik M, Cetin O, Korkmaz H, Surer H, Erel O (2016) Impairment of thiol-disulfide homeostasis in preeclampsia. J Matern Fetal Neonatal Med 3:1–6
11. Bektas H, Vural G, Gumusyayla S, Deniz O, Alisik M, Erel O (2016) Dynamic thiol-disulfide homeostasis in acute ischemic stroke patients. Acta Neurol Belg 116(4):489–494
12. Ates I, Kaplan M, Yuksel M, Mese D, Alisik M, Erel Ö, Yilmaz N, Guler S (2016) Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 51(1):47–51
13. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J et al (1999) Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 10:259–264
14. Erel O, Neselioglu S (2014) A novel and automated assay for thiol/disulfide homeostasis. Clin Biochem. doi:10.1016/j.clinbiochem.2014.09.026
15. Mlakar SJ, Osredkar J, Prezelj J, Marc J (2012) Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values inpostmenopausal women: a genetic association analysis. Menopause 19(3):368–376
16. Sendur OF, Turan Y, Tastaban E, Serter M (2009) Antioxidant status in patients with osteoporosis: a controlled study. Joint Bone Spine 76(5):514–518
17. Wu Q, Zhong ZM, Pan Y, Zeng JH, Zheng S, Zhu SY, Chen JT (2015) Advanced oxidation protein products as a novel marker of oxidative stress in postmenopausal osteoporosis. Med Sci Monit 21:2428–2432
18. Zhong ZM, Bai L, Chen JT (2009) Advanced oxidation protein products inhibit proliferation and differentiation of rat osteoblast-like cells via NF-kappaB pathway. Cell Physiol Biochem 24:105–114
19. Sun N, Yang L, Li Y, Zhang H, Chen H, Liu D, Li Q, Cai D (2013) Effect of advanced oxidation protein products on the proliferation and osteogenic differentiation of rat mesenchymal stem cells. Int J Mol Med 32(2):485–491. doi:10.3892/ijmm.2013.1402
20. Zeng JH, Zhong ZM, Li XD, Wu Q, Zheng S, Zhou J, Ye WB, Xie F, Wu XH, Huang ZP, Chen JT (2014) Advanced oxidation protein products accelerate bone deterioration in aged rats. Exp Gerontol 50:64–71
21. D’Erasmo E, Pisani D, Ragno A, Raejntroph N, Letizia C, Acca M (1999) Relationship between serum albumin and bone mineral density in postmenopausal women and in patients with hypoalbuminemia. Horm Metab Res 31(6):385–388
22. Afshinnia F, Wong KK, Sundaram B, Ackermann RJ, Pennathur S (2016) Hypoalbuminemia and osteoporosis: reappraisal of a controversy. J Clin Endocrinol Metab 101(1):167–175
23. Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ, Jones DP (1999) Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 27(11–12):1208–1218
24. Nkabyo YS, Ziegler TR, Gu LH, Watson WH, Jones DP (2002) Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol Gastrointest Liver Physiol 283(6):G1352–G1359